Cochrane · systematic review · CD010217
Transurethral radiofrequency collagen denaturation for the treatment of women with urinary incontinence
Kang, D, Han, J, Neuberger, MM, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
IncontinenceAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 2 · 28.6%Very low 0 · 0%Low 5 · 71.4%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Transurethral radiofrequency collagen denaturation compared with no treatment/sham treatment for women with UI
Population: women with symptomatic UI
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Participant‐reported measures: number of women reporting UI symptoms Transurethral radiofrequency collagen denaturation vs no treatment/sham treatment | no estimate extracted | 0 studies · 0 participants | Ungraded |
Serious adverse events Transurethral radiofrequency collagen denaturation vs no treatment/sham treatment | no estimate extracted | 1 study · 173 participants | Low Downgraded: risk of bias |
Disease‐specific quality of life: number of women with an I‐QOL score improvement ≥ 10 points at 12 months Transurethral radiofrequency collagen denaturation vs no treatment/sham treatment | RR 1.11 [0.77, 1.62] | 1 study · 142 participants | Low Downgraded: risk of bias |
Repeat continence surgery: number of women undergoing repeat continence surgery Transurethral radiofrequency collagen denaturation vs no treatment/sham treatment | no estimate extracted | 0 studies · 0 participants | Ungraded |
Other adverse event: pain/dysuria: dysuria Transurethral radiofrequency collagen denaturation vs no treatment/sham treatment | RR 5.73 [0.75, 43.7] | 1 study · 173 participants | Low Downgraded: risk of bias |
Other adverse event: (new) detrusor overactivity: overactive bladder symptoms Transurethral radiofrequency collagen denaturation vs no treatment/sham treatment | RR 1.36 [0.63, 2.93] | 1 study · 173 participants | Low Downgraded: risk of bias |
Other adverse event: urinary tract infection Transurethral radiofrequency collagen denaturation vs no treatment/sham treatment | RR 0.95 [0.24, 3.86] | 1 study · 173 participants | Low Downgraded: risk of bias |